Dublin, OH, United States of America

Chenglong Li

USPTO Granted Patents = 9 

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Location History:

  • Dublin, OH (US) (2014 - 2020)
  • Gainesville, FL (US) (2022)

Company Filing History:


Years Active: 2014-2022

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Chenglong Li

Introduction

Chenglong Li is a prominent inventor based in Dublin, Ohio, known for his significant contributions to the field of pharmaceutical sciences. With a total of nine patents to his name, he has made remarkable advancements in the treatment of various diseases and disorders.

Latest Patents

Among his latest patents are innovative compounds that act as IL-6 inhibitors, which are crucial in treating diseases mediated by IL-6. His work includes methods for treating disorders associated with this interleukin, showcasing his commitment to addressing inflammatory conditions. Additionally, he has developed methods and compositions for the inhibition of STAT3, particularly focusing on prodrug compositions of STAT inhibitor compounds. These pharmaceutical compositions are designed to treat inflammatory disorders, including multiple sclerosis and certain types of cancer, highlighting the therapeutic potential of his inventions.

Career Highlights

Chenglong Li has worked with the Ohio State Innovation Foundation, where he has contributed to various research initiatives aimed at advancing medical treatments. His career reflects a dedication to innovation and the application of scientific research to real-world health challenges.

Collaborations

Throughout his career, Chenglong has collaborated with notable professionals in his field, including Robert A Baiocchi and Hongshan Lai. These partnerships have further enriched his research and development efforts.

Conclusion

Chenglong Li's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patents and collaborations continue to pave the way for new treatments that address critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…